Select Publications

Journal articles

Ananda S; Steer C, 2005, 'Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer', Women's Oncology Review, 5, pp. 109 - 111, http://dx.doi.org/10.1080/14733400500178618

Marx GM; Steer CB; Harper PG, 2005, 'Reply to the letter "Limitations of bedside estimates of renal function", by M. J. Dooley and S. G. Poole', ANNALS OF ONCOLOGY, 16, pp. 990 - 990, http://dx.doi.org/10.1093/annonc/mdi174

Dooley MJ; Poole SG; Marx GN; Steer CB; Harper PG, 2005, 'Limitations of Wright formula estimates of renal function (multiple letters) [3]', Annals of Oncology, 16, pp. 989 - 990, http://dx.doi.org/10.1093/annonc/mdi173

Ananda S; Steer C, 2005, 'Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer', The Women's Oncology Review, 5, pp. 109 - 111, http://dx.doi.org/10.3109/14733400500178618

Chrystal K; Steer CB; Cheong KA; Galani E; Strickland A; Lofts F; Gallagher C; Thomas H; Harper P, 2004, 'Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with advanced epithelial ovarian cancer. A phase II trial of sequential doublets. (GO-FIRST)', Journal of Clinical Oncology, 22, pp. 5034 - 5034, http://dx.doi.org/10.1200/jco.2004.22.90140.5034

Chrystal K; Steer CB; Cheong KA; Galani E; Strickland A; Lofts F; Gallagher C; Thomas H; Harper P, 2004, 'Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with advanced epithelial ovarian cancer. A phase II trial of sequential doublets. (GO-FIRST)', Journal of Clinical Oncology, 22, pp. 5034 - 5034, http://dx.doi.org/10.1200/jco.2004.22.14_suppl.5034

Coombes RC; Hall E; Gibson LJ; Paridaens R; Jassem J; Delozier T; Jones SE; Alvarez I; Bertelli G; Ortmann O; Coates AS; Bajetta E; Dodwell D; Coleman RE; Fallowfield LJ; Mickiewicz E; Andersen J; Lonning PE; Cocconi G; Stewart A; Stuart N; Snowdon CF; Carpentieri M; Massimini G; Bliss JM; Warren M; Steer C, 2004, 'A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer', Women's Oncology Review, 4, pp. 135 - 136, http://dx.doi.org/10.1080/14733400410001728483

Marx GM; Blake GM; Galani E; Steer CB; Harper SE; Adamson KL; Bailey DL; Harper PG, 2004, 'Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients', Annals of Oncology, 15, pp. 291 - 295, http://dx.doi.org/10.1093/annonc/mdh079

Chua Y; Steer C; Yip C, 2004, 'Recent advances in management of small-cell lung cancer', Cancer Treatment Reviews, 30, pp. 521 - 543

Karapetis CS; Strickland AH; Yip D; Steer C; Harper PG, 2003, 'Use of fluorodeoxyglucose positron emission tomography scans in patients with advanced germ cell tumour following chemotherapy: Single-centre experience with long-term follow up', Internal Medicine Journal, 33, pp. 427 - 435, http://dx.doi.org/10.1046/j.1445-5994.2003.00456.x

Ring A; Marx G; Steer C; Prendiville J; Ellis P, 2003, 'Poor uptake of influenza vaccinations in patients receiving cytotoxic chemotherapy', International Journal of Clinical Practice, 57, pp. 542 - 543

Galani E; Marx GM; Steer CB; Culora G; Harper PG, 2003, 'Pseudomyxoma peritonei: The 'controversial' disease', International Journal of Gynecological Cancer, 13, pp. 413 - 418, http://dx.doi.org/10.1046/j.1525-1438.2003.13318.x

Yip D; Karapetis C; Strickland AH; Steer C; Holford C; Knight S; Harper P, 2003, 'A dose-escalating study of oral eniluracil/5-fluorouracil plus oxaliplatin in patients with advanced gastrointestinal malignancies', Annals of Oncology, 14, pp. 864 - 866, http://dx.doi.org/10.1093/annonc/mdg254

Galani E; Marx GM; Steer CB; Culora G; Harper PG, 2003, 'Pseudomyxoma peritonei: the ‘controversial’ disease', International Journal of Gynecologic Cancer, 13, pp. 413 - 418, http://dx.doi.org/10.1136/ijgc-00009577-200307000-00003

Ring A; Marx G; Steer C; Harper P, 2002, 'Influenza vaccination and chemotherapy: A shot in the dark?', Supportive Care in Cancer, 10, pp. 462 - 465, http://dx.doi.org/10.1007/s00520-001-0337-9

Strickland AH; Beechey-Newman N; Steer CB; Harper PG, 2002, 'Sentinel node biopsy: An in depth appraisal', Critical Reviews in Oncology/Hematology, 44, pp. 45 - 70, http://dx.doi.org/10.1016/S1040-8428(02)00018-5

Steer CB; Marx GM; Galani E; Harper PG; Khayat D, 2002, 'Quality of life: It's never too late', Journal of Clinical Oncology, 20, pp. 2915 - 2917, http://dx.doi.org/10.1200/JCO.2002.20.13.2915

Marx GM; Steer CB; Harper P; Pavlakis N; Rixe O; Khayat D, 2002, 'Unexpected serious toxicity with chemotherapy and antiangiogenic combinations: Time to take stock!', Journal of Clinical Oncology, 20, pp. 1446 - 1448, http://dx.doi.org/10.1200/JCO.2002.20.6.1446

Steer C; Yip D, 2002, 'Symptom palliation in advanced oesophageal cancer', Current Therapeutics, 43, pp. 33 - 35

Blake GM; Steer CB; Galani E; Marx GM; Adamson K; Bailey D, 2002, 'P10. Effect of GFR methodology on carboplatin dosing', Nuclear Medicine Communications, 23, pp. 408 - 408, http://dx.doi.org/10.1097/00006231-200204000-00090

Yip D; Steer C; Al-Nawab M; Van Der J; Harper P, 2001, 'Collecting duct carcinoma of the kidney associated with the sickle cell trait', International Journal of Clinical Practice, 55, pp. 415 - 417

Steer C; Harper P, 2001, 'Is there any place for cytotoxic chemotherapy in endometrial cancer?', Best Practice and Research: Clinical Obstetrics and Gynaecology, 15, pp. 447 - 467, http://dx.doi.org/10.1053/beog.2001.0188

Steer CB; Marx GM; Harper PG, 2001, 'Is there quality in clinical benefit?', Annals of Oncology, 12, pp. 1191 - 1193, http://dx.doi.org/10.1023/A:1012474308888

Yip D; Karapetis C; Steer C, 2001, 'Management of small cell lung cancer', Expert Review of Anticancer Therapy, 1, pp. 197 - 210, http://dx.doi.org/10.1586/14737140.1.2.197

Steer CB; Szer J; Sasadeusz J; Matthews JP; Beresford JA; Grigg A, 2000, 'Varicella-zoster infection after allogeneic bone marrow transplantation: Incidence, risk factors and prevention with low-dose aciclovir and ganciclovir', Bone Marrow Transplantation, 25, pp. 657 - 664, http://dx.doi.org/10.1038/sj.bmt.1702190

Jenkins MA; Steer CB; Cheng LWH; Ratnaike S, 1999, 'An unusual alkaline phosphatase isoenzyme associated with gastric carcinoma', ANNALS OF CLINICAL BIOCHEMISTRY, 36, pp. 743 - 748, http://dx.doi.org/10.1177/000456329903600607

Conference Papers

Kottege D; Toomeh E; Steer C; Bohensky M; Spiteri C; Swales O; Nagada N; Lucherini S; Hughes R, 2021, 'Modelling the societal outcomes of immunotherapy in cancer care in Australia', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 66 - 66, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Blackberry I; Steer C; Rasekaba T; Young K; Webb N; Jayasuriya D; Owen K; Kapur M, 2021, 'GERIATRIC ONCOLOGY IN THE INSTAGRAM ERA: PHOTOVOICE TO ENABLE PATIENT-CENTERED CARE AND SHARED DECISION MAKING', in INNOVATION IN AGING, OXFORD UNIV PRESS, pp. 26 - 26, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000842009900094&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Soo W-K; King M; Pope A; Steer CB; Devitt BA; Chua SLL; Parente P; Davis ID; Darzins P, 2020, 'ELderly Functional Index (ELFI): Validation of a self-reported measure of functional status in cancer patients.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 May 2020 - 31 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000560368307097&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mileshkin LR; Posner A; Pattison A; Balachander S; Etemadmoghadam D; Fellowes A; Wong HL; Dow E; DeFazio A; Gao B; Karapetis CS; Singh MS; Collins IM; Steer C; Warren MA; Karanth N; Bowtell D; Prall OWJ; Tothill R, 2020, 'Identifying biomarkers to guide immunotherapy treatment of cancer of unknown primary.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 May 2020 - 31 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000560368305219&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sandhu S; Kasturi V; Guminski A; Steer C; Atkinson V; Nordman I; Tobin P; Reed J; Costa N, 2019, 'Avelumab treatment of metastatic merkel cell carcinoma (mMCC): Updated findings from Australian patients enrolled in an expanded access program(EAP)', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 184 - 184, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400298&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Elbourne H; O'Reilly V; Soo K; Norden M; Moran A; Steer C, 2019, 'Exercise and androgen deprivation therapy: Current practice and future direction at a regional cancer centre', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 198 - 198, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400328&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Alidina AA; Steer CC; Nwebb N; Shamim M; Long DD; Eek R; Clarke K; Underhill C; Shahrokni A, 2019, 'Feasibility of the electronic rapid fitness assessment (eRFA) in an Australian regional cancer centre', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 194 - 194, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400320&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Steer C; Toomeh E; Englund A-M; Bohensky M; Spiteri C; Davies N; Nagda N; Lucherini S, 2019, 'Modelling the health outcomes of immuno-oncology therapies in cancer care in Australia', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 151 - 152, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400230&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Goh JC; Baron-Hay S; Bonaventura T; Buck M; Dean A; Friedlander M; Gao B; Mileshkin L; Oehler MK; Steer C; Vi N; Goble S; Grechko N; Monk BJ; Kristeleit RS, 2018, 'ATHENA (GOG-3020/ENGOT-ov45): A randomised, double-blind, placebo-controlled, phase 3 study of rucaparib plus nivolumab following front-line platinum-based chemotherapy in ovarian cancer', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 196 - 196, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449544200343&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

van Hagen T; Sandhu S; Kasturi V; Steer C; Khoo C; Nordman I; Hennessy M; Hildemann S; Reed J; Hariharan S, 2018, 'Avelumab treatment of Australian patients with metastatic Merkel cell carcinoma (mMCC): Experience from an expanded access program (EAP)', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 173 - 174, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449544200294&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Steer C, 2017, 'Safe Delivery of Immunotherapy: A Private Cancer Physician's Perspective', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 88 - 89, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413954500078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Francis J; Steer C; Nelson A; Anderson K; Larment C; Zorbas H; Chynoweth J, 2014, 'FIRST-LINE CHEMOTHERAPY FOR EPITHELIAL OVARIAN CANCER: A NATIONAL APPROACH TO GUIDELINE RECOMMENDATIONS TO ENCOURAGE BEST PRACTICE', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, LIPPINCOTT WILLIAMS & WILKINS, pp. 229 - 229, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344966500182&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Yip S; Pavlakis N; Harvie R; Martin A; Hudson A; Thompson JF; Long A; Steer C; Stockler MR; Davis ID, 2014, 'CIRCULATING BIOMARKERS AND OUTCOMES IN A PHASE 2 TRIAL OF FIRST-LINE EVEROLIMUS ALTERNATING WITH SUNITINIB FOR ADVANCED RENAL CELL CARCINOMA (ANZUP 0901-THE EVERSUN TRIAL)', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, pp. E65 - E65, http://dx.doi.org/10.1016/j.ejca.2014.03.245

Yip S; Pavlakis N; Harvie R; Martin A; Jovanovic L; Hudson A; Thompson JF; Nelson C; Long A; Steer C; Harrison ML; Kannourakis G; Goldstein D; Kichenadasse G; Lowenthal RM; Stockler MR; Davis ID, 2014, 'Circulating biomarkers and outcomes in a single-arm phase II trial of first-line sunitinib alternating with everolimus for advanced renal cell carcinoma (aRCC): EVERSUN ANZUP trial 0901', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, presented at Genitourinary Cancers Symposium, CA, San Francisco, 30 January 2014 - 01 February 2014, http://dx.doi.org/10.1200/jco.2014.32.4_suppl.428

Davis ID; Long A; Martin A; Espinoza D; Yip S; Kichenadasse G; Thompson JF; Harrison ML; Lowenthal RM; Pavlakis N; Azad A; Kannourakis G; Steer C; Goldstein D; Shapiro JD; Stockler MR, 2014, 'EVERSUN: A phase II trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (aRCC) (ANZUP trial 0901)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, presented at Genitourinary Cancers Symposium, CA, San Francisco, 30 January 2014 - 01 February 2014, http://dx.doi.org/10.1200/jco.2014.32.4_suppl.438

Booms A; Healy Z; Underhill C; Eek R; Steer C; Clarke K; Commins J, 2013, 'INTRODUCING THE NURSE PRACTITIONER ROLE TO IMPROVE REGIONAL ONCOLOGY PATIENT OUTCOMES', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 136 - 136, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800241&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Steer C, 2013, 'OVARIAN CANCER IN THE ELDERLY - THE ROLE OF SURGERY AND SYSTEMIC TREATMENT', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 67 - 67, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Steer C, 2013, 'PRACTICE PEARLS: WHAT IS DIFFERENT WHEN DEALING WITH THE OLDER PATIENT? A MEDICAL ONCOLOGIST'S PERSPECTIVE', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 62 - 62, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Anuradha S; Webb P; Jordan S; Blomfield P; Friedlander M; Leung Y; Obermair A; Oehler M; Quinn M; Steer C, 2013, 'SURVIVAL OF AUSTRALIAN WOMEN WITH EPITHELIAL OVARIAN CANCER - A POPULATION-BASED STUDY', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 81 - 81, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800072&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Vergote IB; Joly F; Katsaros D; Coens C; Reinthaller A; Hall M; Steer CB; Colombo N; Lesoin A; Casado A; Petru E; Green J; Buck M; Ray-Coquard IL; Ferrero A; Favier L; Reed N; Curve H; Jimeno A; Pujade-Lauraine E, 2012, 'Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: A GCIG and EORTC-GCG study.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 01 June 2012 - 06 June 2012, http://dx.doi.org/10.1200/jco.2012.30.18_suppl.lba5000

Steer C, 2008, 'Renal function in the elderly', in Cancer Forum, pp. 11 - 16

Lichtman SM; Wildiers H; Launay-Vacher V; Steer C; Chatelut E; Aapro M, 2007, 'Chemotherapy in elderly patients with renal insufficiency. Recommendations of the International Society of Geriatric Oncology (SIOG)', in EJC SUPPLEMENTS, PERGAMON-ELSEVIER SCIENCE LTD, SPAIN, Barcelona, pp. 174 - 174, presented at 14th European Cancer Conference (ECCO 14), SPAIN, Barcelona, 23 September 2007 - 27 September 2007, http://dx.doi.org/10.1016/S1359-6349(07)70726-7

Launay-Vacher V; Chatelut E; Lichtman SM; Wildiers H; Steer C; Aapro M, 2007, 'Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology (SIOG) clinical practice recommendations.', in EJC SUPPLEMENTS, PERGAMON-ELSEVIER SCIENCE LTD, SPAIN, Barcelona, pp. 175 - 175, presented at 14th European Cancer Conference (ECCO 14), SPAIN, Barcelona, 23 September 2007 - 27 September 2007, http://dx.doi.org/10.1016/S1359-6349(07)70729-2

Chrystal K; Steer CB; Cheong KA; Galani E; Strickland A; Lofts F; Gallagher C; Thomas H; Harper P, 2004, 'Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with advanced epithelial ovarian cancer. A phase II trial of sequential doublets. (GO-FIRST).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, LA, New Orleans, pp. 457S - 457S, presented at 40th Annual Meeting of the American-Society-of-Clinical-Oncology, LA, New Orleans, 05 June 2004 - 08 June 2004, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000223512401812&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1


Back to profile page